This paper focuses on the importance of full disclosure in disorders of sex development (DSD), as a universal human right and closely related to informed consent. Full disclosure is not only a way of communicating a diagnosis, it is a methodological constant that permeates all the clinical moments expressed by a multidisciplinary team. As stated by The Chicago consensus, DSD should be referred to specialized centers of excellence. In these centers provided with the necessary multidisciplinary team that is able to: provide knowledge, skills and experience; deliver quality and care, and cope with the emotional barriers that often hinder the practice of full disclosure. Full disclosure is important when a person is informed about something, can participate in making a decision or is advised about something that needs to be done before he/she will be able to make a choice. However, if a person is informed about something that was done unnecessarily and could have been postponed until he/she could have been involved in making the decision, full disclosure can be seen as deception colored by rage, sorrow and regret.

Brinkmann L, Schutzmann K, Richter-Appelt H: Gender assignment and medical history of individuals with different forms of intersexuality: evaluation of medical records and the patients’ perspective. J Sex Med 4:964–980 (2007).
Carmichael P, Ransley PG: Telling children about a physical intersex condition. Dialogues Pediatr Urol 25:7–8 (2002).
Creighton S, Minto CL: Managing intersex. BMJ 323:1264–1265 (2001).
Creighton S, Minto CL, Steele SJ: Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood. Lancet 358:124–125 (2001).
Hughes A, Houk C, Ahamed SF, Lee PA; LWPES/ESPE Consensus Group: Consensus statement on managing of intersex disorders. Arch Dis Child 91:554–563 (2006).
Kanzakis K: Fixing Sex: Intersex, Medical Authority and Lived Experience. (Duke University Press, Durham and London 2008).
Liao LM: Learning to assist women born with atipic genitalia: journey through ignorance, taboo and dilemma. J Reprod Infant Psyc 21:229–238 (2003).
Liao LM, Green H, Creighton SM, Crouch NS, Conway GS: Patient experiences of obtaining and giving information about disorder of sex development. BJOG-Int J Obstet Gy 117:193–199 (2010).
Menzies IE: A case in the functioning of social systems as a defence against anxiety: a report on a study of the nursing service of a general hospital. Hum Relat 13:95–121 (1960).
Money J, Hampson JG, Hampson JL: Hermaphroditism. Recommendations concerning assignment of sex, change of sex and psychological management. Bull Johns Hopkins Hosp 97:284–300 (1955).
Slijper FM, Frets PG, Boehmer AL, Drop SL, Niermeijer MF: Androgen insensitivity syndrome (AIS) emotional reactions of parents and adult patients to the clinical diagnosis of AIS and its confirmation by androgen receptor gene mutation analysis. Horm Res 53:9–15 (2000).
Sutton A: ‘Lesley’: the struggle of a teenager with an intersex disorder to find an identity – its impact on the ‘I’ of the beholder, in Di Ceglie D, Freeman D (eds): A Stranger in My Own Body – Atypical Gender Identity Development and Mental Health (Karnac Books, London 1998).
Wisniewski AB, Migeon CJ, Heino FL, Meyer-Bahlburg JP, Berkovitz GD, et al: Complete androgen insensitivity syndrome: long-term medical, surgical and psychosexual outcome. J Clin Endocrinol Metab 85:2664–2669 (2000).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.